Amarin Corp Plcuk (AMRN) Asset Utilization Ratio (2013 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Asset Utilization Ratio of 0.29 for Q2 2026, down 11.38% year-over-year from 0.33 in Q2 2025, and down 10.95% quarter-over-quarter from 0.33 in Q1 2026.
Amarin Corp Plcuk (AMRN) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Asset Utilization Ratio for 14 consecutive years, with 0.29 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 11.38% year-over-year to 0.29; the TTM figure through Jun 2026 stood at 0.29 (down 11.38% YoY), while the FY2025 annual figure was 0.32, up 4.54% from the prior year.
- Asset Utilization Ratio declined to 0.29 in Q2 2026 per AMRN's latest filing, from 0.33 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.52 in Q1 2022 and bottomed at 0.29 in Q2 2026.
- Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.34 in 2025.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio retreated 25.78% — and 2025, when it grew 9.67%.
- Amarin Corp Plc\Uk's Asset Utilization Ratio stood at 0.41 in 2022, then dropped by 10.71% to 0.37 in 2023, then fell by 13.33% to 0.32 in 2024, then increased by 0.85% to 0.32 in 2025, then fell by 8.69% to 0.29 in 2026.
- Business Quant data shows AMRN's Asset Utilization Ratio at 0.29 in Q2 2026, 0.33 in Q1 2026, and 0.32 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.64 |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.29 |
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.32 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | 0.37 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.49 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.58 |